A UK Multicentre, Health-Related Quality of Life Study for Children and Adolescents With XLH
A UK Multicentre, Non-interventional, Observational, Health-Related Quality of Life Study for Children and Adolescents With X-linked Hypophosphataemia
Sponsor: Kyowa Kirin Pharmaceutical Development Ltd
Listed as NCT04819490, this observational or N/A phase trial focuses on X-Linked Hypophosphataemia and remains completed. Sponsored by Kyowa Kirin Pharmaceutical Development Ltd, it has been updated 11 times since 2021, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Aug 2024 — Sep 2024 [monthly]
Completed
-
Jul 2024 — Aug 2024 [monthly]
Completed
-
Jun 2023 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Sep 2022 — Jun 2023 [monthly]
Recruiting
▶ Show 6 earlier versions
-
Apr 2022 — Sep 2022 [monthly]
Recruiting
-
Feb 2022 — Apr 2022 [monthly]
Recruiting
-
Nov 2021 — Feb 2022 [monthly]
Recruiting
-
Oct 2021 — Nov 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2021 — Oct 2021 [monthly]
Not Yet Recruiting
-
Apr 2021 — Sep 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Kyowa Kirin Pharmaceutical Development Ltd
For direct contact, visit the study record on ClinicalTrials.gov .